Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
A New Approach to Autoimmunity
Using Multi-Omic Technology to Reclassify and Improve Treatment for Autoimmune Disease
For full access to this article login to GEN Select now.
Increasing America's Competitiveness with Fewer Ph.D.s
In PNAS paper, co-authors argue nation's biomedical system is unsustainable.
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.